Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt‐based anti‐cancer drugs

Publisher： John Wiley & Sons Inc

E-ISSN： 1460-2075|34|24|2993-3008

ISSN： 0261-4189

Source： THE EMBO JOURNAL, Vol.34, Iss.24, 2015-12, pp. : 2993-3008

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alterations of Circadian Rhythms in Mice Induced by Anti-Cancer Drugs

By Peleg L.   Rienstein S.   Ron I.   Dotan A.   Wolfson S.   Ashkenazi I.E.  

Biological Rhythm Research, Vol. 29, Iss. 1, 1998-02 ,pp. : 98-104

Taylor & Francis Ltd

Access to resources Recommend Favorite

Pharmacokinetics of Selected Anticancer Drugs in Elderly Cancer Patients: Focus on Breast Cancer

By Crombag Marie-Rose B.S.   Joerger Markus   Thürlimann Beat   Schellens Jan H.M.   Beijnen Jos H.   Huitema Alwin D.R.  

Cancers, Vol. 8, Iss. 1, 2016-01 ,pp. : 6-6

MDPI

Access to resources Recommend Favorite

Cellular and Organismal Toxicity of the Anti-Cancer Small Molecule, Tolfenamic Acid: a Pre-Clinical Evaluation

By  

Cellular Physiology and Biochemistry, Vol. 32, Iss. 3, 2013-09 ,pp. : 675-686

Karger

Access to resources Recommend Favorite

Synthesis and anti-cancer efficacy of rapid hydrolysed water-soluble paclitaxel pro-drugs

By Ryu Beom-Young   Sohn Jeong-Sun   Hess Michael   Choi Soo-Kyung   Choi Jae-Kon   Jo Byung-Wook  

Journal of Biomaterials Science, Polymer Edition, Vol. 19, Iss. 3, 2008-03 ,pp. : 311-324

Taylor & Francis Ltd

Access to resources Recommend Favorite

The Anti-Cancer Effects of Frondoside A

By Adrian Thomas E.   Collin Peter  

Marine Drugs, Vol. 16, Iss. 2, 2018-02 ,pp. : 64-64

MDPI

Access to resources Recommend Favorite